Systemic Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Immune Today - Breaking & Trending Today

Clinical Laserthermia Systems Americas, Inc.: Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS' Co-founder Professor Karl-Göran Tranberg Published in the Journal Frontiers in Oncology


Article Overview
Current immune-based therapies, particularly checkpoint blockade, have improved cancer therapy in a major way, but most patients do not respond favorably to immunotherapy, pointing to the need for new or complementary approaches. Physically based Local Destruction of Tumors (LDT) methods can induce immunologic effects and contribute to anti-tumor immune activity. The present review examined abscopal effects induced by presently available local destruction methods, such as radiofrequency ablation, focal laser ablation, cryotherapy and radiotherapy, without or with combination with immunotherapy. The abscopal effect denotes regression of established distant untreated tumors after any form of local treatment and is considered to be the strongest indicator of a relevant immunologic effect. ....

Senior Clinical Advisor , Professor Karl G , Local Destruction , Systemic Immune , Thermoguide Workstation , Nasdaq First North Growth Market , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,

Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS' Co-founder Professor Karl-Göran Tranberg Published in the Journal "Frontiers in Oncology"


Home / Top News / Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review article titled “Local Destruction of Tumors and Systemic Immune Effects” has been published in the Journal “Frontiers in Oncology” by the company’s co-founder and Senior Clinical Advisor, Professor Karl-Göran Tranberg. ....

Clinical Laserthermia Systems , Systemic Immune , Senior Clinical Advisor , Professor Karl G , Local Destruction , Thermal Therapy System , Thermoguide Workstation , Nasdaq First North Growth Market , Certified Advisor , வெப்ப சிகிச்சை அமைப்பு , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,